Cronos (CRON) Shares Outstanding (Diluted Average) (2017 - 2022)
Cronos (CRON) recorded quarterly Shares Outstanding (Diluted Average) of $375.0 million in Q1 2022, up 0.89% quarter-over-quarter from $371.7 million in Q2 2021, and up 3.31% on a YoY basis from $363.0 million in Q1 2021.
Cronos (CRON) Shares Outstanding (Diluted Average) (2017 - 2022) Analysis & Trends
Cronos' Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $375.0 million for Q1 2022.
- In Q1 2022, Shares Outstanding (Diluted Average) rose 3.31% year-over-year to $375.0 million; the TTM figure through Mar 2022 stood at $375.0 million (up 3.31% YoY), while the FY2020 annual figure was $351.6 million, changed N/A from the prior year.
- Shares Outstanding (Diluted Average) was $375.0 million for Q1 2022 at Cronos, up from $371.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $375.0 million in Q1 2022 to a low of $130.5 million in Q4 2018.
- Historically, Shares Outstanding (Diluted Average) has averaged $342.4 million across 5 years, with a median of $367.1 million in 2019.
- The sharpest annual moves came in 2018 and 2021: Shares Outstanding (Diluted Average) dropped 6.21% in 2018, then rose 6.53% in 2021.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $130.5 million in 2018, then soared by 182.93% to $369.3 million in 2019, then retreated by 4.79% to $351.6 million in 2020, then gained by 5.73% to $371.7 million in 2021, then rose by 0.89% to $375.0 million in 2022.
- The last three Shares Outstanding (Diluted Average) figures came in at $375.0 million (Q1 2022), $371.7 million (Q2 2021), and $363.0 million (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Cronos | 1.06 Bn | 284.85 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 375.02 Mn |
| Jun 30, 2021 | 371.72 Mn |
| Mar 31, 2021 | 363.01 Mn |
| Dec 31, 2020 | 351.58 Mn |
| Sep 30, 2020 | 374.73 Mn |
| Jun 30, 2020 | 348.95 Mn |
| Mar 31, 2020 | 374.33 Mn |
| Sep 30, 2019 | 369.27 Mn |
| Jun 30, 2019 | 364.87 Mn |
| Dec 31, 2018 | 130.51 Mn |
| Dec 31, 2017 | 139.16 Mn |